A biotech company with an AI-approach to developing new TCRs for immunotherapy asked Alacrita to assist in preparations for the J.P. Morgan Healthcare conference.
Alacrita supported the company in preparing for the conference by identifying and shortlisting prospective partners, specifically biotech/pharma companies active in the TCR and/or cell therapy space. Our experienced pharmaceutical business development consultants helped the company prepare non-confidential and confidential slide decks for initial presentation at the conference, and follow-on discussions with interested parties, respectively.
In-Licensing & Asset Scouting Support
Alacrita supports both large pharma and biotech companies with their search and evaluation activities. Our scouting support is often structured to integrate with the client’s internal efforts, resulting in a constant flow of new opportunities.Back